Alzheimer Disease
Showing NaN - NaN of 49
Alzheimer, Cognitive Dysfunction, Dementia Trial in Worldwide (JNJ-63733657, Placebo)
Recruiting
- Alzheimer Disease
- +2 more
- JNJ-63733657
- Placebo
-
Birmingham, Alabama
- +143 more
Jan 31, 2023
Alzheimer Trial in United States (15mg T3D-959, 30 mg T3D-959, 45 mg T3D-959)
Active, not recruiting
- Alzheimer Disease
- 15mg T3D-959
- +3 more
-
Phoenix, Arizona
- +41 more
Jan 23, 2023
Mild Cognitive Impairment, Alzheimer Trial in United States (Donanemab, Aducanumab)
Active, not recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
-
Fullerton, California
- +30 more
Jan 18, 2023
Alzheimer Trial in United States (AV-1959D, Placebo)
Not yet recruiting
- Alzheimer Disease
- AV-1959D
- Placebo
-
Phoenix, Arizona
- +5 more
Dec 22, 2022
Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation,Psychomotor Trial in Canada, United States
Completed
- Agitation in Patients With Dementia of the Alzheimer's Type
- +2 more
- AXS-05
- Placebo
-
Sun City, Arizona
- +62 more
Dec 13, 2022
Alzheimer, Mild Cognitive Impairment Trial in United States (Florbetapir F 18 PET Scan)
Active, not recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
- Florbetapir F 18 PET Scan
-
Anaheim, California
- +76 more
Sep 21, 2022
Database to Investigate Blood-Based and Digital Biomarkers in
Recruiting
- Alzheimer Disease
- +5 more
- Biomarker Data Collection
-
Aventura, Florida
- +15 more
Sep 21, 2022
Alzheimer Trial in Worldwide (Gantenerumab, Placebo)
Active, not recruiting
- Alzheimer Disease
- Gantenerumab
- Placebo
-
Phoenix, Arizona
- +156 more
Jul 4, 2022
Alzheimer, Dementia, Brain Diseases Trial in Canada, United States (No Intervention, donanemab)
Active, not recruiting
- Alzheimer Disease
- +4 more
- No Intervention
- donanemab
-
Phoenix, Arizona
- +27 more
May 25, 2022
Alzheimer Trial in Worldwide (COR388 capsule, Placebo capsule)
Completed
- Alzheimer Disease
- COR388 capsule
- Placebo capsule
-
Phoenix, Arizona
- +92 more
Mar 8, 2022
Alzheimer Trial in Worldwide (BI 425809 dose 1, BI 425809 dose 2, BI 425809 dose 3)
Completed
- Alzheimer Disease
- BI 425809 dose 1
- +4 more
-
Colton, California
- +94 more
Oct 16, 2020
Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer, Agitation,Psychomotor Trial in Australia, United States
Completed
- Agitation in Patients With Dementia of the Alzheimer's Type
- +2 more
- AXS-05
- +2 more
-
Phoenix, Arizona
- +61 more
Oct 7, 2020
Alzheimer Trial in Canada, United States (Flortaucipir F18, Brain PET Scan)
Completed
- Alzheimer Disease
- Flortaucipir F18
- Brain PET Scan
-
San Diego, California
- +9 more
Aug 7, 2020
Alzheimer Trial in Worldwide (lecozotan SR (SRA-333))
Completed
- Alzheimer Disease
- lecozotan SR (SRA-333)
-
Phoenix, Arizona
- +82 more
Jul 1, 2020
Alzheimer, Alzheimer, Late Onset Trial in Tampa (MemorEM 1000)
Unknown status
- Alzheimer Disease
- Alzheimer Disease, Late Onset
- MemorEM 1000
-
Tampa, FloridaByrd Alzheimer's Institute, University of South Florida
Feb 24, 2020